Iceland

Iceland

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.89 (0.06 - 10.33) 2015 Modelled WHO
0.14 (0.04 - 0.56) 2013 Modelled Schweitzer et al, 2015
0.65 (0.53 - 0.77) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.72 (0.59 - 0.84) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.59 - 0.86) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.60 - 0.87) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.60 - 0.88) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.60 - 0.88) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.60 - 0.88) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.87) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.87) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.88) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.88) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.61 - 0.87) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.62 - 0.88) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.62 - 0.88) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.62 - 0.88) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.62 - 0.89) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.63 - 0.89) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.63 - 0.90) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.64 - 0.91) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.63 - 0.92) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.64 - 0.92) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.64 - 0.92) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.63 - 0.92) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.63 - 0.92) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.63 - 0.93) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.63 - 0.94) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.63 - 0.94) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.63 - 0.95) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.63 - 0.97) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.63 - 0.98) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.58 - 0.84) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.88 (0.06 - 10.46) 2015 Modelled WHO
0.3 (0.20 - 0.41) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.51 (0.34 - 0.72) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.34 - 0.74) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.53 (0.33 - 0.76) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.34 - 0.77) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.34 - 0.77) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.35 - 0.77) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.36 - 0.77) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.36 - 0.77) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.53 (0.36 - 0.77) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.53 (0.35 - 0.77) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.53 (0.36 - 0.76) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.53 (0.36 - 0.75) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.37 - 0.74) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.37 - 0.74) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.37 - 0.74) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.55 (0.37 - 0.74) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.38 - 0.76) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.38 - 0.77) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.38 - 0.79) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.38 - 0.79) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.39 - 0.79) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.39 - 0.78) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.39 - 0.77) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.39 - 0.76) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.38 - 0.76) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.39 - 0.77) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.39 - 0.78) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.39 - 0.79) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.38 - 0.81) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.38 - 0.84) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.05 - 0.40) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of persons living with chronic HBV

National
Download
Value Year Type Source
2,233 (1,827 - 2,641) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2,298 (1,880 - 2,708) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2,289 (1,874 - 2,678) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,275 (1,854 - 2,704) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,267 (1,859 - 2,704) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,257 (1,845 - 2,722) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2,233 (1,826 - 2,670) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2,213 (1,799 - 2,634) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,201 (1,787 - 2,620) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,196 (1,779 - 2,614) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,196 (1,776 - 2,610) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,194 (1,784 - 2,602) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,178 (1,782 - 2,566) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,147 (1,768 - 2,523) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,107 (1,741 - 2,482) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,070 (1,711 - 2,443) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,048 (1,701 - 2,419) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,041 (1,688 - 2,405) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,039 (1,687 - 2,408) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,032 (1,680 - 2,412) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,014 (1,650 - 2,391) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,991 (1,643 - 2,358) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,970 (1,621 - 2,336) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,954 (1,595 - 2,312) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,942 (1,573 - 2,296) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,930 (1,556 - 2,306) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,919 (1,550 - 2,294) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,908 (1,536 - 2,292) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,898 (1,518 - 2,291) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,888 (1,498 - 2,290) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,880 (1,469 - 2,309) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.32 (1.02 - 1.72) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.02 (0.78 - 1.31) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.80 - 1.32) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.81 - 1.34) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.06 (0.82 - 1.34) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.84 - 1.38) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.87 - 1.42) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (0.88 - 1.45) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (0.88 - 1.44) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.13 (0.88 - 1.45) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.12 (0.87 - 1.43) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.86 - 1.40) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.86 - 1.41) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.12 (0.86 - 1.41) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.86 - 1.40) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.12 (0.86 - 1.41) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (0.88 - 1.44) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.89 - 1.47) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.89 - 1.48) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.89 - 1.47) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.19 (0.91 - 1.50) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.17 (0.90 - 1.48) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.93 - 1.53) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.24 (0.95 - 1.58) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (0.96 - 1.61) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (0.94 - 1.57) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (0.99 - 1.66) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.24 (0.95 - 1.59) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (0.96 - 1.61) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1 - 1.70) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.02 - 1.72) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
4 2016 Modelled WHO
3 (2 - 3) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 3) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 3) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2019 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
5 (3 - 7) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 11) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2018 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2019 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Source:
Year of HCV elimination goal
2025
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.3 (0.20 - 0.40) 2015 Modelled Blach et al, 2017
0.3 (0.30 - 0.40) 2014 Modelled Olafsson S et al, 2018
0.68 (0.55 - 0.83) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.55 - 0.83) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.55 - 0.83) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.54 - 0.81) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.52 - 0.79) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.52 - 0.79) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.53 - 0.79) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.53 - 0.79) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.53 - 0.80) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.52 - 0.79) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.52 - 0.79) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.52 - 0.79) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.52 - 0.79) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.52 - 0.78) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.52 - 0.78) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.52 - 0.78) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.51 - 0.77) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.51 - 0.77) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.51 - 0.77) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.50 - 0.76) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.50 - 0.76) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.50 - 0.75) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.49 - 0.75) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.49 - 0.75) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.49 - 0.74) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.49 - 0.74) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.49 - 0.74) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.49 - 0.74) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.49 - 0.74) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.49 - 0.75) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.51 - 0.77) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
63 (59.80 - 66.20) 1993 Survey/reported Love A et al, 1994
Technical notes

Number of persons living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
1,000 (1,000 - 1,000) 2015 Modelled Blach et al, 2017
1,415 (1,145 - 1,759) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1,424 (1,158 - 1,773) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,435 (1,170 - 1,786) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,448 (1,180 - 1,794) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,462 (1,188 - 1,814) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,478 (1,203 - 1,836) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,498 (1,217 - 1,851) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,522 (1,237 - 1,882) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,549 (1,263 - 1,915) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,580 (1,285 - 1,944) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,609 (1,312 - 1,983) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,638 (1,335 - 2,019) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,665 (1,359 - 2,052) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,690 (1,380 - 2,084) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,718 (1,405 - 2,114) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,750 (1,427 - 2,156) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,790 (1,466 - 2,206) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,832 (1,502 - 2,264) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,870 (1,529 - 2,306) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,898 (1,541 - 2,336) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,915 (1,558 - 2,356) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,926 (1,570 - 2,372) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,931 (1,576 - 2,374) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,938 (1,579 - 2,384) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,955 (1,591 - 2,398) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,984 (1,613 - 2,442) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2,052 (1,680 - 2,507) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,123 (1,741 - 2,607) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,162 (1,773 - 2,648) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,191 (1,789 - 2,674) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2,168 (1,770 - 2,651) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
2.15 (1.66 - 2.70) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.3 (1.04 - 1.58) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.06 - 1.61) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.08 - 1.64) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.39 (1.11 - 1.66) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.44 (1.15 - 1.73) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.51 (1.21 - 1.82) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.56 (1.25 - 1.89) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.58 (1.27 - 1.92) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.28 - 1.94) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.59 (1.27 - 1.92) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.57 (1.26 - 1.90) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.59 (1.28 - 1.93) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.29 - 1.96) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.30 - 1.99) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.32 - 2.02) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.34 - 2.08) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.73 (1.35 - 2.12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.38 - 2.16) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.77 (1.38 - 2.17) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (1.41 - 2.21) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.45 - 2.27) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.50 - 2.36) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.99 (1.54 - 2.46) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.03 (1.58 - 2.52) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.99 (1.54 - 2.48) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.02 (1.55 - 2.54) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (1.63 - 2.64) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.60 - 2.58) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.67 - 2.71) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.66 - 2.70) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
14 2016 Modelled WHO
7 (6 - 9) 2019 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 2019 Modelled IHME, GBD 2019 (accessed 2020)
7 (6 - 9) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 7) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 7) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
12 (9 - 16) 1990 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 1991 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 1992 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 18) 1994 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 17) 1993 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 1995 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 1996 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 21) 1997 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 22) 1998 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 22) 1999 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 2000 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 23) 2001 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 25) 2004 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 25) 2003 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 2002 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 26) 2005 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 27) 2006 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 29) 2008 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 28) 2007 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 30) 2009 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 31) 2010 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 32) 2011 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 34) 2013 Modelled IHME, GBD 2019 (accessed 2022)
26 (20 - 33) 2012 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 35) 2014 Modelled IHME, GBD 2019 (accessed 2022)
28 (21 - 37) 2017 Modelled IHME, GBD 2019 (accessed 2022)
28 (20 - 35) 2015 Modelled IHME, GBD 2019 (accessed 2022)
28 (21 - 36) 2016 Modelled IHME, GBD 2019 (accessed 2022)
29 (22 - 37) 2018 Modelled IHME, GBD 2019 (accessed 2022)
28 (21 - 36) 2019 Modelled IHME, GBD 2019 (accessed 2022)
38 (29 - 48) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
190 2017 Survey/reported ECDC, 2019
190 2017 Survey/reported The European Centre for Disease Prevention and Control, 2019
Showing out of
Show more
Females
Download
Value Year Type Source
168 2016 Survey/reported Olafsson et al., 2018
Males
Download
Value Year Type Source
358 2016 Survey/reported Olafsson et al., 2018
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Source:
Year of HCV elimination goal
2025
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal
Year of goal
2025

Prevalence (national)

Modelled

HBV (HBsAg+)
0.71 (%)
2019
(0.58 - 0.84(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
0.63 (%)
2019
(0.51 - 0.77(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
5
2019
(4 - 6)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
7
2019
(6 - 9)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.15 (%)
2020, latest modelled
(0.05 - 0.40(%))
WHO

Prevalence PWID

HCV
63 (%)
1993, survey/surveillance
(59.80 - 66.20(%))
Love A et al, 1994

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs